CY1107270T1 - Φαρμακευτικες συνθεσεις για κεφαλαλγια, ημικρανια, ναυτια και εμετο - Google Patents

Φαρμακευτικες συνθεσεις για κεφαλαλγια, ημικρανια, ναυτια και εμετο

Info

Publication number
CY1107270T1
CY1107270T1 CY20081100071T CY081100071T CY1107270T1 CY 1107270 T1 CY1107270 T1 CY 1107270T1 CY 20081100071 T CY20081100071 T CY 20081100071T CY 081100071 T CY081100071 T CY 081100071T CY 1107270 T1 CY1107270 T1 CY 1107270T1
Authority
CY
Cyprus
Prior art keywords
migrants
marine
heads
vehicle
pharmaceutical compositions
Prior art date
Application number
CY20081100071T
Other languages
English (en)
Inventor
Raphael Barkan
Alexander Mirimsky
Original Assignee
Meditor Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL14463201A external-priority patent/IL144632A0/xx
Application filed by Meditor Pharmaceuticals Ltd. filed Critical Meditor Pharmaceuticals Ltd.
Publication of CY1107270T1 publication Critical patent/CY1107270T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Αποκαλύπτεται η χρήση παραγώγων S-αλκυλισοθειοουρονίου, όπως, αλλά μη περιοριζόμενο σε αυτήν, της προτιμώμενης ένωσης διαιθυλφωσφορικό S-αιθυλισοθειοουρόνιο, για τη θεραπεία κεφαλαλγίας, συγκεκριμένα ημικρανίας, καθώς επίσης για την πρόληψη ή τη θεραπεία ναυτίας και έμετου. Οι συνθέσεις της εφεύρεσης είναι αποτελεσματικές στην αποτροπή ή την ανακούφιση έμετου που συνδυάζεται με ημικρανία ή άλλες ιατρικές καταστάσεις, όπως χημειοθεραπεία ή ραδιοθεραπεία, καθώς επίσης άλλα συμπτώματα ημικρανίας που συμπεριλαμβάνουν φωνοφοβία και φωτοφοβία.
CY20081100071T 2000-09-05 2008-01-17 Φαρμακευτικες συνθεσεις για κεφαλαλγια, ημικρανια, ναυτια και εμετο CY1107270T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22981200P 2000-09-05 2000-09-05
IL14463201A IL144632A0 (en) 2001-07-30 2001-07-30 Method and pharmaceutical compositions for treating headache, nausea and migraine
EP01965546A EP1315505B1 (en) 2000-09-05 2001-08-30 Pharmaceutical compositions for headache, migraine, nausea and emesis

Publications (1)

Publication Number Publication Date
CY1107270T1 true CY1107270T1 (el) 2012-11-21

Family

ID=26324036

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081100071T CY1107270T1 (el) 2000-09-05 2008-01-17 Φαρμακευτικες συνθεσεις για κεφαλαλγια, ημικρανια, ναυτια και εμετο

Country Status (22)

Country Link
US (2) US7148208B2 (el)
EP (1) EP1315505B1 (el)
JP (1) JP2004508311A (el)
KR (1) KR100849999B1 (el)
CN (1) CN100448439C (el)
AT (1) ATE375797T1 (el)
AU (2) AU2001286178B2 (el)
BR (1) BR0113698A (el)
CA (1) CA2420410C (el)
CY (1) CY1107270T1 (el)
DE (1) DE60131004T2 (el)
DK (1) DK1315505T3 (el)
ES (1) ES2296792T3 (el)
HK (1) HK1058009A1 (el)
HU (1) HUP0302362A3 (el)
IL (1) IL154456A (el)
MD (1) MD2447G2 (el)
MX (1) MXPA03001737A (el)
NO (1) NO20031902L (el)
NZ (1) NZ524903A (el)
PT (1) PT1315505E (el)
WO (1) WO2002019961A2 (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ524903A (en) * 2000-09-05 2004-11-26 Meditor Pharmaceuticals Ltd Pharmaceutical compositions comprising S-alkylisothiouronium derivatives for headache, migraine, nausea and emesis
WO2007108004A2 (en) * 2006-03-23 2007-09-27 Meditor Pharmaceuticals Ltd. S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
EA200901591A1 (ru) * 2007-06-13 2010-06-30 Медитор Фармасьютикалс Лтд. Фармацевтические композиции производных s-алкилизотиоурония с маскированным вкусом
EP2219447B1 (en) * 2007-11-06 2013-07-03 Barkan-Farma S.r.l. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
MD3619G2 (ro) * 2007-11-06 2009-01-31 Рафаэль Баркан Remediu medicamentos nazal cu acţiune anticongestivă
US9560967B2 (en) 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US20100069724A1 (en) * 2008-04-24 2010-03-18 Searete Llc Computational system and method for memory modification
US8682687B2 (en) 2008-04-24 2014-03-25 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US20100063368A1 (en) * 2008-04-24 2010-03-11 Searete Llc, A Limited Liability Corporation Computational system and method for memory modification
US8876688B2 (en) 2008-04-24 2014-11-04 The Invention Science Fund I, Llc Combination treatment modification methods and systems
US8615407B2 (en) 2008-04-24 2013-12-24 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US8930208B2 (en) 2008-04-24 2015-01-06 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US8606592B2 (en) 2008-04-24 2013-12-10 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US9662391B2 (en) 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
US9239906B2 (en) 2008-04-24 2016-01-19 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US9649469B2 (en) 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US9064036B2 (en) 2008-04-24 2015-06-23 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US7974787B2 (en) * 2008-04-24 2011-07-05 The Invention Science Fund I, Llc Combination treatment alteration methods and systems
US9026369B2 (en) 2008-04-24 2015-05-05 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US20100130811A1 (en) * 2008-04-24 2010-05-27 Searete Llc Computational system and method for memory modification
US20090270687A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for modifying bioactive agent use
US8357117B2 (en) * 2008-08-06 2013-01-22 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
WO2012018341A1 (en) * 2010-08-05 2012-02-09 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
CN109523244B (zh) * 2018-11-02 2023-06-27 创新先进技术有限公司 一种基于母子账户的用于转移款项数据的方法和系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419675A1 (fr) * 1978-03-16 1979-10-12 Philagro Sa Compositions fongicides a base de phosphites d'isothiouronium
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
MD263C2 (ro) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ Remediu cu acţiune antihipotensivă "IZOTURON"
MD586C2 (ro) * 1995-05-25 1997-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Substanţă medicamentoasă cu acţiune antihipotensivă "Difetur"
FR2753098B1 (fr) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
EP0928191B1 (en) * 1996-09-26 2002-08-28 Meditor Pharmaceuticals Ltd. Pharmaceutical compositions comprising s-alkylisothiouronium derivatives
WO1998019674A2 (en) * 1996-11-05 1998-05-14 Head Explorer Aps A method for treating tension-type headache
MD1138C2 (ro) * 1997-02-17 1999-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Izopropilfosfit-S-izopropilizotiuroniu- substanţă cu acţiune hipertensivă
MD1223C2 (ro) * 1997-07-15 2000-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Aplicarea dimetilfosfatului de S-metil-izo-tiouroniu în calitate de substanţă vasoconstrictoare şi preparat farmaceutic pe baza lui
US6127420A (en) * 1997-08-22 2000-10-03 The Medical College Of Wisconsin Research Foundation, Inc. L-N5 -(1-imino-3-alkenyl) ornithine and related compounds and use thereof
MD1431G2 (ro) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Remedii antihipotensive
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
FR2788771B1 (fr) * 1999-01-22 2001-04-13 Pf Medicament Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique
US6489308B1 (en) * 1999-03-05 2002-12-03 Trustees Of University Of Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions
ATE399025T1 (de) * 1999-07-21 2008-07-15 Omeros Corp Spüllösungen und verfahren zur schmerzhemmung, entzündungshemmung und hemmung des knorpelabbaus
NZ524903A (en) * 2000-09-05 2004-11-26 Meditor Pharmaceuticals Ltd Pharmaceutical compositions comprising S-alkylisothiouronium derivatives for headache, migraine, nausea and emesis

Also Published As

Publication number Publication date
KR20030055257A (ko) 2003-07-02
KR100849999B1 (ko) 2008-08-01
MD2447F2 (en) 2004-05-31
BR0113698A (pt) 2003-12-09
NO20031902L (no) 2003-06-09
CN100448439C (zh) 2009-01-07
US20070088005A1 (en) 2007-04-19
MXPA03001737A (es) 2004-09-10
AU2001286178B2 (en) 2006-09-14
MD2447G2 (ro) 2005-12-31
HUP0302362A3 (en) 2005-05-30
ATE375797T1 (de) 2007-11-15
MD20020139A (en) 2002-11-30
ES2296792T3 (es) 2008-05-01
HUP0302362A2 (hu) 2003-11-28
WO2002019961A2 (en) 2002-03-14
US20040006044A1 (en) 2004-01-08
NZ524903A (en) 2004-11-26
WO2002019961A3 (en) 2002-08-15
EP1315505B1 (en) 2007-10-17
DE60131004D1 (de) 2007-11-29
CA2420410A1 (en) 2002-03-14
EP1315505A2 (en) 2003-06-04
CN1464788A (zh) 2003-12-31
IL154456A (en) 2013-05-30
HK1058009A1 (en) 2004-04-30
PT1315505E (pt) 2008-01-28
DE60131004T2 (de) 2008-07-31
JP2004508311A (ja) 2004-03-18
US7148208B2 (en) 2006-12-12
US8673979B2 (en) 2014-03-18
DK1315505T3 (da) 2008-03-03
NO20031902D0 (no) 2003-04-28
EP1315505A4 (en) 2006-02-22
CA2420410C (en) 2011-04-26
AU8617801A (en) 2002-03-22

Similar Documents

Publication Publication Date Title
CY1107270T1 (el) Φαρμακευτικες συνθεσεις για κεφαλαλγια, ημικρανια, ναυτια και εμετο
CY1119882T1 (el) Παραγωγο πυριμιδινης ως αναστολεας ρι3κ και χρηση αυτου
CY1123919T1 (el) 1η-βενζιμιδαζολο-4-καρβοξαμιδια υποκατεστημενα με τεταρτοταγη ανθρακα στην 2-θεση ειναι ισχυροι αναστολεις parp
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
EA200500893A1 (ru) Трициклические соединения, представляющие собой ингибиторы протеинкиназ, для увеличения эффективности противоопухолевых агентов и лучевой терапии
CY1120081T1 (el) Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90
CY1115417T1 (el) Τροποποιημενα 2’ και 3’-νουκλεοζιτικα προφαρμακα για θεραπεια μολυνσεων απο flaviviridae
CY1113538T1 (el) Παραγωγα της 5-αμινο-2,4,7-τριοξο-3,4,7,8-τετραϋδρο-2η-πυριδο[2,3-d] πυριμιδινης και παρομοιες ενωσεις για την αγωγη του καρκινου
NO20075099L (no) Alkynyl-pyrrolopyrmidiner og relaterte analoger som HSP90-inhibitorer
BR9917080A (pt) Composto, composição farmacêutica, uso do composto e método de tratamento ou prevenção de uma disfunção tromboembólica
CY1110074T1 (el) Ενωσεις βενζιμιδαζολιου
CY1113989T1 (el) Ρυθμιστες 2,3-διοξυγενασης ινδολοαμινης και μεθοδοι χρησης αυτων
TR200200118T2 (tr) Yeni bileşimler
BRPI0606524A2 (pt) derivados de indol para o tratamento de infecções virais
CY1106674T1 (el) Αζαδικυκλικοι ετεροκυκλοι σαν ρυθμιστες υποδοχεα κανναβινοειδους
CY1111087T1 (el) Παραγωγα 5-(βενζ-(ζ)-υλιδενο)-θειαζολιδιν-4-ονης ως ανοσοκατασταλτικοι παραγοντες
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
ATE384058T1 (de) Thiazolderivate
MXPA05010000A (es) Derivados de p-diaminobenceno substituidos.
TW200637817A (en) 5-aminoindole derivatives
CY1113171T1 (el) Αντιφλεγμονωδεις παραγοντες
ATE492534T1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
DE602006014022D1 (de) 5-substituierte indol-2-carbonsäureamidderivate
BR0314352A (pt) Indóis 2,7-substituìdos e seu uso como moduladores de 5-ht6
BRPI0713333A2 (pt) Potencializador de terapia de radiação